These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18837240)

  • 1. Cardiac biomarkers and chronic renal diseases.
    Valocikova I; Kristofova B; Valocik G
    Bratisl Lek Listy; 2008; 109(8):341-4. PubMed ID: 18837240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in chronic kidney disease: utility and issues towards better understanding.
    Zoccali C
    Curr Opin Nephrol Hypertens; 2005 Nov; 14(6):532-7. PubMed ID: 16205471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early markers of cardiovascular risk in chronic kidney disease.
    Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
    Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New markers of accelerated atherosclerosis in end-stage renal disease.
    Rattazzi M; Puato M; Faggin E; Bertipaglia B; Grego F; Pauletto P
    J Nephrol; 2003; 16(1):11-20. PubMed ID: 12649530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD.
    Mallamaci F; Tripepi G; Cutrupi S; Malatino LS; Zoccali C
    Kidney Int; 2005 Jun; 67(6):2330-7. PubMed ID: 15882276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
    Nanayakkara PW; Teerlink T; Stehouwer CD; Allajar D; Spijkerman A; Schalkwijk C; ter Wee PM; van Guldener C
    Kidney Int; 2005 Nov; 68(5):2230-6. PubMed ID: 16221223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.
    Sommerer C; Giannitsis E; Schwenger V; Zeier M
    Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for the prediction of mortality and morbidity in patients with renal replacement therapy.
    Chaykovska L; Tsuprykov O; Hocher B
    Clin Lab; 2011; 57(7-8):455-67. PubMed ID: 21888009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy.
    James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L
    Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of cardiac biomarkers in end-stage renal disease.
    Wang AY; Lai KN
    J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
    Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
    Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin Measurements During Albumin Replacement in Patients With Severe Sepsis or Septic Shock.
    Masson S; Caironi P; Fanizza C; Carrer S; Caricato A; Fassini P; Vago T; Romero M; Tognoni G; Gattinoni L; Latini R;
    Crit Care Med; 2016 Apr; 44(4):707-16. PubMed ID: 26571184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biomarkers in cardiology--state of the art 2007].
    Mair J
    Wien Med Wochenschr; 2007 Feb; 157(3-4):48-56. PubMed ID: 17340059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding cardiac biomarkers in end-stage kidney disease: Frequently asked questions and the promise of clinical application.
    Roberts MA; Hedley AJ; Ierino FL
    Nephrology (Carlton); 2011 Mar; 16(3):251-60. PubMed ID: 21342319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure.
    ; Wu AH; Jaffe AS; Apple FS; Jesse RL; Francis GL; Morrow DA; Newby LK; Ravkilde J; Tang WH; Christenson RH; ; Cannon CP; Storrow AB
    Clin Chem; 2007 Dec; 53(12):2086-96. PubMed ID: 17954494
    [No Abstract]   [Full Text] [Related]  

  • 17. Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease.
    Hallén J; Madsen L; Ladefoged S; Fagerland MW; Serebruany VL; Agewall S; Atar D
    Scand J Urol Nephrol; 2011 Mar; 45(2):151-8. PubMed ID: 21091090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
    Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E;
    J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic utility of cardiac biomarkers in dialysis patients.
    Wang AY; Wai-Kei Lam C
    Semin Dial; 2012 Jul; 25(4):388-96. PubMed ID: 22748194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.
    Tuñón J; Blanco-Colio L; Cristóbal C; Tarín N; Higueras J; Huelmos A; Alonso J; Egido J; Asensio D; Lorenzo Ó; Mahíllo-Fernández I; Rodríguez-Artalejo F; Farré J; Martín-Ventura JL; López-Bescós L
    Am J Cardiol; 2014 Feb; 113(3):434-40. PubMed ID: 24295549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.